35 PRIMECAP Management Abiomed Trades
The first Abiomed trade was made in Q1 2013. Since then PRIMECAP Management bought shares two more times and sold shares on 32 occasions. The investor completely sold their stake between Q4 2015 and Q4 2022.
Avg closing price
Price range
Sold -1.51 Million shares
Q4 2022
Avg closing price
$332.97
Price range
$242.77
-
$381.30
Sold 2.1% shares (-33 Thousand shares)
Q3 2022
Avg closing price
$270.04
Price range
$242.49
-
$301.46
Sold 4.4% shares (-71.4 Thousand shares)
Q2 2022
Avg closing price
$269.85
Price range
$224.73
-
$338.64
Sold 3.4% shares (-57 Thousand shares)
Q1 2022
Avg closing price
$307.83
Price range
$277.25
-
$366.29
Sold 7.4% shares (-133 Thousand shares)
Q4 2021
Avg closing price
$337.86
Price range
$300.63
-
$371.35
Sold 3.0% shares (-56.3 Thousand shares)
Q3 2021
Avg closing price
$338.77
Price range
$310.19
-
$376.20
Sold 3.2% shares (-61.3 Thousand shares)
Q2 2021
Avg closing price
$306.77
Price range
$262.71
-
$351.17
Sold 6.3% shares (-130 Thousand shares)
Q1 2021
Avg closing price
$320.02
Price range
$285.92
-
$355.13
Sold 7.9% shares (-176 Thousand shares)
Q4 2020
Avg closing price
$276.60
Price range
$251.88
-
$324.20
Sold 15.9% shares (-419 Thousand shares)
Q3 2020
Avg closing price
$288.09
Price range
$255.22
-
$317.00
Sold 9.6% shares (-282 Thousand shares)
Q2 2020
Avg closing price
$200.79
Price range
$141.40
-
$257.09
Sold 5.1% shares (-158 Thousand shares)
Q1 2020
Avg closing price
$166.01
Price range
$130.51
-
$196.01
Sold 0.1% shares (-3 Thousand shares)
Q4 2019
Avg closing price
$185.40
Price range
$159.31
-
$223.54
Sold 1.4% shares (-45.2 Thousand shares)
Q3 2019
Avg closing price
$216.16
Price range
$175.89
-
$279.23
Sold 0.6% shares (-18 Thousand shares)
Q2 2019
Avg closing price
$265.32
Price range
$250.96
-
$284.94
Sold 2.5% shares (-81.2 Thousand shares)
Q1 2019
Avg closing price
$332.35
Price range
$276.39
-
$362.25
Sold 4.2% shares (-142 Thousand shares)
Q4 2018
Avg closing price
$347.37
Price range
$281.08
-
$444.25
Sold 5.3% shares (-190 Thousand shares)
Q3 2018
Avg closing price
$394.20
Price range
$354.53
-
$449.75
Sold 6.8% shares (-261 Thousand shares)
Q2 2018
Avg closing price
$362.28
Price range
$278.07
-
$446.21
Sold 6.3% shares (-257 Thousand shares)
Q1 2018
Avg closing price
$253.43
Price range
$192.49
-
$295.85
News about Abiomed Inc. and PRIMECAP Management
Top 5 3rd Quarter Trades of Polar Asset Management Partners Inc.
Related Stocks: NOA , SRPT , IGV , LNTH , ABMD ,
Paloma Partners Management Co Invests $864,000 in Abiomed, Inc. (NASDAQ:ABMD)
Paloma Partners Management Co bought a new position in Abiomed, Inc. (NASDAQ:ABMD) in the 2nd quarter, Holdings Channel.com reports. The institutional invest...